Description: Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Home Page: www.revvity.com
0KHE Technical Analysis
940 Winter Street
Waltham,
MA
02451
United States
Phone:
781 663 6900
Officers
| Name | Title |
|---|---|
| Dr. Prahlad R. Singh Ph.D. | CEO, President & Director |
| Mr. Maxwell Krakowiak | Senior VP & CFO |
| Mr. Tajinder S. Vohra | Senior Vice President of Global Operations |
| Mr. Joel S. Goldberg | Senior VP of Administration, General Counsel & Secretary |
| Ms. Miriame Victor | Senior VP & Chief Commercial Officer |
| Mr. Andrew Okun | VP, Chief Accounting Officer & Treasurer |
| Mr. Bryan A. Kipp | Senior Vice President of Technology & Licensing |
| Ms. Madhuri Hegde FACMG, Ph.D. | Senior VP & Chief Scientific Officer |
| Mr. Stephen Barr Willoughby | Senior VP of Investor Relations & Head of ESG |
| Ms. Magali Four | Senior VP and Chief People & Culture Officer |
Exchange: LSE
Country: GB : United Kingdom of Great Britain and Northern Ireland
Currency: US Dollar ($)
| GIC Sector: | Industrials |
|---|---|
| GIC Group: | Commercial & Professional Services |
| GIC Industry: | Commercial Services & Supplies |
| GIC Sub-Industry: | Environmental & Facilities Services |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0.1887 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 4.7105 |
| IPO Date: | |
| Fiscal Year End: | January |
| Full Time Employees: | 11000 |